After almost two years of planning and three digital events, the first ever, in-person Brain Innovation Days, led by the European Brain Council, took place on 12-13 October 2021 in Brussels, Belgium.

Alzheimer Europe is delighted to have co-authored a new paper, published in the journal Alzheimer's Research & Therapy, called ‘Dementia risk communication. A user manual for Brain Health Services’.

In November 2021, the European Pain Federation and Pain Alliance Europe organised the annual SIP forum. For the second year in a row, we met virtually due to the COVID-19 pandemic.

Read the latest reports on EAN clinical fellowships in Innsbruck (AT) and Linz (AT)

Read the latest reports on EAN clinical fellowships in Dianalund (DK) and London (UK)

7th Swiss Narcolepsy Day – 22 January, 2022

57th Turkish Neurology Congress – 27 November to 1 December

On 3-4 September, 2021, the Virtual Regional Teaching Course in Turkey took place, with more than 250 local medical professionals participating in the online event.

The latest webinar in a series on inspiring people in neurosciences will focus on the renowned expert on tropical neurology, Prof. Michel Dumas.

On 31 July, 2021, a programme of highlights from the EAN 2021 Virtual Conress was held online especially to give Chinese neurolgists a taste of Europe's largest neurology meeting.

Follow-up interview with Emilia Gatto, Head of the Neurology Department at Sanatorio de la Trinidad Mitre and Head of the Movement Disorders Section of the Institute of Neuroscience Buenos Aires

We are happy to announce the first Regional Teaching Course to take place in Nicosia, Cyprus on 11-13 March, 2022.

On 16 September, 2021 the Virtual EAN-Day took place in Chisinau, Republic of Moldova, organised by the EAN and the Society of Neurologists of the Republic of Moldova.

This very large epidemiological study calculated stroke incidence, prevalence, mortality, disability-adjusted life-years and the population attributable fraction of disability-adjusted life years associated with 19 risk factors, for 204 countries from 1990 to 2019.

The aim of this study was to describe the clinical characteristics and outcome of patients with cerebral venous sinus thrombosis after SARS-CoV-2 vaccination.